These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 25003381)
41. Computational Approaches to Identification of Aggregation Sites and the Mechanism of Amyloid Growth. Dovidchenko NV; Galzitskaya OV Adv Exp Med Biol; 2015; 855():213-39. PubMed ID: 26149932 [TBL] [Abstract][Full Text] [Related]
43. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784 [TBL] [Abstract][Full Text] [Related]
44. Amino acid sequence determinants and molecular chaperones in amyloid fibril formation. Nerelius C; Fitzen M; Johansson J Biochem Biophys Res Commun; 2010 May; 396(1):2-6. PubMed ID: 20494101 [TBL] [Abstract][Full Text] [Related]
45. Spontaneous and BSE-prion-seeded amyloid formation of full length recombinant bovine prion protein. Panza G; Stöhr J; Dumpitak C; Papathanassiou D; Weiss J; Riesner D; Willbold D; Birkmann E Biochem Biophys Res Commun; 2008 Sep; 373(4):493-7. PubMed ID: 18585368 [TBL] [Abstract][Full Text] [Related]
46. Molecular mechanisms of polypeptide aggregation in human diseases. Khare SD; Dokholyan NV Curr Protein Pept Sci; 2007 Dec; 8(6):573-9. PubMed ID: 18220844 [TBL] [Abstract][Full Text] [Related]
47. Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides. Nguyen HD; Hall CK Proc Natl Acad Sci U S A; 2004 Nov; 101(46):16180-5. PubMed ID: 15534217 [TBL] [Abstract][Full Text] [Related]
48. Apolipoproteins and amyloid fibril formation in atherosclerosis. Teoh CL; Griffin MD; Howlett GJ Protein Cell; 2011 Feb; 2(2):116-27. PubMed ID: 21400045 [TBL] [Abstract][Full Text] [Related]
49. Structural characteristics of short peptides in solution. Ohtake S; Kita Y; Payne R; Manning M; Arakawa T Protein Pept Lett; 2013 Dec; 20(12):1308-23. PubMed ID: 24261976 [TBL] [Abstract][Full Text] [Related]
50. Insights into amyloid fibril formation from mass spectrometry. Caddy GL; Robinson CV Protein Pept Lett; 2006; 13(3):255-60. PubMed ID: 16515453 [TBL] [Abstract][Full Text] [Related]
51. pH-induced molecular shedding drives the formation of amyloid fibril-derived oligomers. Tipping KW; Karamanos TK; Jakhria T; Iadanza MG; Goodchild SC; Tuma R; Ranson NA; Hewitt EW; Radford SE Proc Natl Acad Sci U S A; 2015 May; 112(18):5691-6. PubMed ID: 25902516 [TBL] [Abstract][Full Text] [Related]
52. Exposure of Aggregation-Prone Segments is the Requirement for Amyloid Fibril Formation. Pramanik S; Ahmad B Curr Protein Pept Sci; 2018; 19(10):1024-1035. PubMed ID: 29779477 [TBL] [Abstract][Full Text] [Related]
53. Influence of the polypeptide environment next to amyloidogenic peptides on fibril formation. Damm S; Schwarz E Biol Chem; 2014 Jul; 395(7-8):699-709. PubMed ID: 25003381 [TBL] [Abstract][Full Text] [Related]
54. Different morphology of amyloid fibrils originating from agitated and non-agitated conditions. Buttstedt A; Wostradowski T; Ihling C; Hause G; Sinz A; Schwarz E Amyloid; 2013 Jun; 20(2):86-92. PubMed ID: 23570235 [TBL] [Abstract][Full Text] [Related]
55. Interpreting the aggregation kinetics of amyloid peptides. Pellarin R; Caflisch A J Mol Biol; 2006 Jul; 360(4):882-92. PubMed ID: 16797587 [TBL] [Abstract][Full Text] [Related]
56. Fibril formation and toxicity of the non-amyloidogenic rat amylin peptide. Milton NG; Harris JR Micron; 2013 Jan; 44():246-53. PubMed ID: 22854213 [TBL] [Abstract][Full Text] [Related]